Metformin Hydrochloride Tablet, Extended Release — FDA Drug Shortage

To Be Discontinued — Mylan Pharmaceuticals Inc., A Viatris Company

The FDA lists a drug shortage record for Metformin Hydrochloride Tablet, Extended Release (tablet) from Mylan Pharmaceuticals Inc., A Viatris Company with status To Be Discontinued. The shortage was first posted on Oct 22, 2026.

Shortage details

Status
To Be Discontinued
Company
Mylan Pharmaceuticals Inc., A Viatris Company
Package NDC
0378-6002-91
Dosage Form
Tablet
Presentation
Metformin Hydrochloride, Tablet, Extended Release, 500 mg (NDC 0378-6002-91)
Initial Posting
Oct 22, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.